General Statement of Disclosure:
RESEARCH/RESEARCH GRANTS: Eli Lilly(SIGNIFICANT), Amgen(SIGNIFICANT), Astra Zeneca(SIGNIFICANT), Esperion Therapeutics(SIGNIFICANT), Pfizer(SIGNIFICANT), Medtronic(NONE), MyoKardia(SIGNIFICANT), Novartis(SIGNIFICANT), Silence Therapeutics(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), AbbVie, Inc.(SIGNIFICANT), Bristol-Myers Squibb Company (SIGNIFICANT), Mineralys(SIGNIFICANT), New Amsterdam Pharmaceuticals(SIGNIFICANT)